vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1208Research ArticleВ ПОМОЩЬ ВРАЧУA DOCTOR’S AIDВАКЦИНОПРОФИЛАКТИКА ПНЕВМОКОККОВОЙ ИНФЕКЦИИ КАК ОДНОЙ ИЗ ПРИЧИН ОСЛОЖНЕНИЙ И ЛЕТАЛЬНОСТИ ПРИ ГРИППЕVACCINE PROPHYLAXIS OF PNEUMOCOCCAL INFECTION AS ONE OF THE REASONS OF COMPLICATIONS AND MORTALITY IN PATIENTS WITH INFLUENZAКостиновМ.П.KostinovM.P.ПахомовД.В.PakhomovD.V.МагаршакО.О.MagarshakO.O.СухининМ.В.SukhininM.V.НИИ вакцин и сывороток им. И.И. Мечникова РАМН, МоскваРоссияI.I. Mechnikov Scientific Center of Vaccines and Serums, Russian Academy of Medical Sciences, MoscowRussian Federation20092409201586Вопросы современной педиатрии131134Copyright © Костинов М., Пахомов Д., Магаршак О., Сухинин М., 20092009Костинов М., Пахомов Д., Магаршак О., Сухинин М.Kostinov M., Pakhomov D., Magarshak O., Sukhinin M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1208ReferencesNeuzil K.M., Mellen B.G., Wright P.F., Mitchel Jr. E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotic in children. N. Engl. J. Med. 2000; 342: 225–231.Neuzil K.M., Mellen B.G., Wright P.F., Mitchel Jr. E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotic in children. N. Engl. J. Med. 2000; 342: 225–231.Smil V. The next 50 years: fatal discontinuities. Pop. Dev. Rev. 2005; 1: 201–236.Smil V. The next 50 years: fatal discontinuities. Pop. Dev. Rev. 2005; 1: 201–236.Henig R.M. The emergence of a new flu. In: A Dancing Matrix; Voyages Along the Viral Frontier. New York: Alfred A. Knopf. 1993.Henig R.M. The emergence of a new flu. In: A Dancing Matrix; Voyages Along the Viral Frontier. New York: Alfred A. Knopf. 1993.Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) United States, May–August 2009. MMWR. 2009; 58 (38): 1071–1074.Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) United States, May–August 2009. MMWR. 2009; 58 (38): 1071–1074.Klugman K.P., Chien Y., Madhi S. Pneumococcal pneumonia and influenza: A deadly combination. Vaccine. 2009; 27: 9–14.Klugman K.P., Chien Y., Madhi S. Pneumococcal pneumonia and influenza: A deadly combination. Vaccine. 2009; 27: 9–14.Hansen J., Black S., Shinefield H., Cherian T., Benson J., Fireman B., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumoniae: updated analysis using World Health Organization standardized interpretation of chest radiation. Pediatr. Infect. Dis. J. 2006; 25: 779–781.Hansen J., Black S., Shinefield H., Cherian T., Benson J., Fireman B., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumoniae: updated analysis using World Health Organization standardized interpretation of chest radiation. Pediatr. Infect. Dis. J. 2006; 25: 779–781.Cherian T., Mulholland E.K., Carlin J.B., Ostensen H., Amin R., de Campo M., et al. WHO Radiology Working Group Standardized interpretation of paediatric chest radiographs for the diagnostics of pneumonia in epidemiological studies. Bull World Health Organ. 2005; 83: 353–359.Cherian T., Mulholland E.K., Carlin J.B., Ostensen H., Amin R., de Campo M., et al. WHO Radiology Working Group Standardized interpretation of paediatric chest radiographs for the diagnostics of pneumonia in epidemiological studies. Bull World Health Organ. 2005; 83: 353–359.Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., Pierce N. Vaccine Trialists Group. A trial of 9-valent pneumococcal conjugate vaccine in children with and those without HIV-infection. N. Engl. J. Med. 2003; 349: 1341–1348.Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., Pierce N. Vaccine Trialists Group. A trial of 9-valent pneumococcal conjugate vaccine in children with and those without HIV-infection. N. Engl. J. Med. 2003; 349: 1341–1348.Cutts F.T., Zaman S.M.A., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Gambial Pneumococcal Vaccine Trial Group. Eficacy of nine valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in Gambia: randomized, double-blind, placebo-controlled trial. Lancet. 2005; 365: 1139–1146.Cutts F.T., Zaman S.M.A., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Gambial Pneumococcal Vaccine Trial Group. Eficacy of nine valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in Gambia: randomized, double-blind, placebo-controlled trial. Lancet. 2005; 365: 1139–1146.Zhou F., Kyaw M.N., Shefer A., Winston C.A., Nuorti J.P. Health care utilization for pneumoniae in young children after routine pneumococcal conjugate vaccine use in the United States. Arch. Pediatr. Adolesc. Med. 2007; 161: 1162–1168.Zhou F., Kyaw M.N., Shefer A., Winston C.A., Nuorti J.P. Health care utilization for pneumoniae in young children after routine pneumococcal conjugate vaccine use in the United States. Arch. Pediatr. Adolesc. Med. 2007; 161: 1162–1168.Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumoniae admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA: a time series analysis. Lancet. 2007; 369: 1179–1186.Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumoniae admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA: a time series analysis. Lancet. 2007; 369: 1179–1186.Brimblecombe F.S.W., Cruickshank R, Masters P.L., Reid D.D., Stewart G.T. Family studies of respiratory infections. BMJ. 1958; 119–128.Brimblecombe F.S.W., Cruickshank R, Masters P.L., Reid D.D., Stewart G.T. Family studies of respiratory infections. BMJ. 1958; 119–128.McCullers J.A., Insights into interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 2006; 19: 571–582.McCullers J.A., Insights into interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 2006; 19: 571–582.Smillie W.G., Warnock G.H., White H.J. A study of a type I pneumococcus epidemic at the state hospital of Worcester M.A. Am. J. Public Health. 1938; 28: 293–302.Smillie W.G., Warnock G.H., White H.J. A study of a type I pneumococcus epidemic at the state hospital of Worcester M.A. Am. J. Public Health. 1938; 28: 293–302.O’Brien K.L., Walters M.L., Sellman J., Quinlisk P., Regenery H., Schwartz B., et al. Severe pneumococcal pneumoniae in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis. 2000; 30: 784–789.O’Brien K.L., Walters M.L., Sellman J., Quinlisk P., Regenery H., Schwartz B., et al. Severe pneumococcal pneumoniae in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis. 2000; 30: 784–789.Stensballe L.G., Hjuller T., Andersen A., Maltoft M., Ravn H., Aaby P. et al. Hospitalization for respiratory syncytial virus infrction and invasive pneumococcal disease: in Danish children aged <2 years: a population based cohort study. Clin. Infect. Dis. 2002; 46: 1165–1171.Stensballe L.G., Hjuller T., Andersen A., Maltoft M., Ravn H., Aaby P. et al. Hospitalization for respiratory syncytial virus infrction and invasive pneumococcal disease: in Danish children aged <2 years: a population based cohort study. Clin. Infect. Dis. 2002; 46: 1165–1171.Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Ziegler T., et al. Epidemiology and clinical characteristics of community acquired pneumoniae in hospitalized children. Pediatrics. 2004; 113: 701–707.Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Ziegler T., et al. Epidemiology and clinical characteristics of community acquired pneumoniae in hospitalized children. Pediatrics. 2004; 113: 701–707.Madhi S.A., Klugman K.P. Vaccine trialist group. A role for Streptococcus pneumonia in virus associated pneumonia. Nat. Med. 2004; 10: 811–813.Madhi S.A., Klugman K.P. Vaccine trialist group. A role for Streptococcus pneumonia in virus associated pneumonia. Nat. Med. 2004; 10: 811–813.Morens D.M., Taubenberger J.K, Fauci A.S. Predominant role of bacterial pneumoniae as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 2008; 198: 962–970.Morens D.M., Taubenberger J.K, Fauci A.S. Predominant role of bacterial pneumoniae as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 2008; 198: 962–970.CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2009; 58 (8).CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2009; 58 (8).
The authors declare that there are no conflicts of interest present.